Welch Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
WP
Welch Group's CLB Position: Q1 2017 in Review
Welch Group sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 1,080 shares — an estimated $130K sold.
Welch Group first reported a position in CLB in Q2 2013 and held it in 15 quarters. The position peaked at $230K in Q1 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.
- Welch Group reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
- Welch Group sold 1,080 Core Laboratories shares in Q1 2017, an estimated $130K.
- Welch Group first reported a position in Core Laboratories in Q2 2013 and held it in 15 quarters.
- Welch Group's Core Laboratories position peaked at $230K in Q1 2014.
- 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.
Based on Welch Group's 13F filing for Q1 2017, filed 2 May 2017.